Enrollment completed in BIOMAG-LL clinical study
The BIOMAG-LL clinical study is evaluating longer lengths for the Freesolve resorbable magnesium scaffold.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The BIOMAG-LL clinical study is evaluating longer lengths for the Freesolve resorbable magnesium scaffold.
Teleflex (NYSE: TFX ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at